Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure

Tolvaptan-induced hypernatremia related to low serum potassium level accompanying high blood pressure in patients with acute decompensated heart failure

Abstract Backgrounds Tolvaptan significantly increases urine volume in acute decompensated heart failure (ADHF); serum sodium level increases due to aquaresis in almost all cases. We aimed to elucidate clinical factors associated with hypernatremia in ADHF patients treated with tolvaptan. Methods We...

Full description

Bibliographic Details
Main Authors: Hidetada Fukuoka, Koichi Tachibana, Yukinori Shinoda, Tomoko Minamisaka, Hirooki Inui, Keisuke Ueno, Soki Inoue, Kentaro Mine, Kumpei Ueda, Shiro Hoshida
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Cardiovascular Disorders
Subjects:
Acute decompensated heart failure
Hypernatremia
Hypokalemia
Tolvaptan
Online Access:http://link.springer.com/article/10.1186/s12872-020-01751-3

Internet

http://link.springer.com/article/10.1186/s12872-020-01751-3

Similar Items